- Home
- Personal stories
Personal stories
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
What is a rheumatic disease?
More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.
What are biologics?
Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.
Care in action: Empowering community health workers to address TB underdiagnosis
J&J CareCommunity is empowering communities to address one of the most significant barriers to ending tuberculosis (TB): underdiagnosis.
Measuring what matters: The evolving role of impact measurement and management
Samatha Curtis from The Good Economy shares four recommendations for impact investors.
J&J Impact Ventures invests in Rology to expand access to critical, high-quality radiology diagnostics
By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.
Bridging the Gap: New J&J CareCommunity collaborations support 70,000 health workers across Latin America
By investing in health workers and local infrastructure, J&J CareCommunity is helping strengthen communities and expand access to care across Latin America.
Accelerating impact: The acquisition of CareAcademy by Activated Insights
With the acquisition, more health workers across the U.S. will be able to access a comprehensive learning platform to develop new skills.